INTRA CELLULAR THERAPIES INC shareholders Q3 2023

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

INTRA CELLULAR THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Covestor Ltd 2,518$1310.10%
Trexquant Investment LP 75,841$3,950,5580.10%
TWINBEECH CAPITAL LP 92,899$4,839,1090.09%
Engineers Gate Manager LP 47,003$2,448,3860.09%
MACQUARIE GROUP LTD 1,367,375$71,227,0000.09%
XTX Topco Ltd 9,021$469,9040.08%
AdvisorShares Investments LLC 5,772$300,6630.08%
Verition Fund Management LLC 130,342$6,789,5150.08%
Assenagon Asset Management S.A. 488,606$25,451,4870.08%
GREAT LAKES ADVISORS, LLC 151,293$7,880,8520.07%
ClearBridge Investments 1,403,601$73,113,5550.07%
FRANKLIN STREET ADVISORS INC /NC 13,783$7180.06%
Atom Investors LP 5,015$261,2310.06%
Regal Investment Advisors LLC 13,610$708,9460.06%
LMR Partners LLP 87,900$4,578,7110.05%
Cyrus J. Lawrence, LLC 3,550$1840.05%
FMR LLC 10,979,710$571,933,1150.05%
St. Louis Trust Co 5,000$260,4500.05%
Hennion & Walsh Asset Management, Inc. 14,764$769,0570.05%
Aquatic Capital Management LLC 22,200$1,1560.05%
External links

This page lists INTRA CELLULAR THERAPIES INC's shareholders in Q3 2023. To view INTRA CELLULAR THERAPIES INC's shareholder history, click here.